| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| FLORES JESSICA | Executive VP & CAO | C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN | /s/ Michael Costa, as Attorney-in-Fact | 12 Feb 2026 | 0002003768 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SBRA | Common Stock | Award | $0 | +3,198 | +3.8% | $0.000000 | 87,744 | 10 Feb 2026 | Direct | F1 |
| transaction | SBRA | Common Stock | Tax liability | $22,444 | -1,172 | -1.3% | $19.15 | 86,572 | 10 Feb 2026 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 672 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025. |
| F2 | Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person. |
| F3 | Includes 25,159 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. |